Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 516

Results For "CE"

8982 News Found

Abbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and International Business
People | January 03, 2025

Abbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and International Business

Prithwish has close to 28 years of experience in a Commercial role


Akums commissions new manufacturing facility for Lyophilized and Sterile dosage
News | January 02, 2025

Akums commissions new manufacturing facility for Lyophilized and Sterile dosage

The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products


FDA grants orphan drug designation to MicuRx's MRX-5 for non-tuberculous mycobacteria infections
Drug Approval | January 02, 2025

FDA grants orphan drug designation to MicuRx's MRX-5 for non-tuberculous mycobacteria infections

MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria


Innovent inks agreement with Roche for Novel DLL3 ADC
News | January 02, 2025

Innovent inks agreement with Roche for Novel DLL3 ADC

Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009


Amcor completes sale of BCNA joint venture interest for $122 million
Packaging | January 02, 2025

Amcor completes sale of BCNA joint venture interest for $122 million

Fiscal 2024 total sales for the joint venture were approximately $190 million


Huadong Medicine and SynerK to jointly develop a novel siRNA drug SNK-2726
R&D | January 02, 2025

Huadong Medicine and SynerK to jointly develop a novel siRNA drug SNK-2726

SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage


Sanofi acquires rights to develop and commercialize Aficamten in Greater China
News | January 01, 2025

Sanofi acquires rights to develop and commercialize Aficamten in Greater China

In 2020, CORXEL acquired the rights to develop and commercialize aficamten in Greater China


Schizophrenia in Children: Understanding Early-Onset Schizophrenia
News | December 31, 2024

Schizophrenia in Children: Understanding Early-Onset Schizophrenia

Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia


Cupid strengthens board with appointment of four new directors
People | December 31, 2024

Cupid strengthens board with appointment of four new directors

Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director


Fortis Healthcare appoints Leo Puri as Chairman of the Board
People | December 28, 2024

Fortis Healthcare appoints Leo Puri as Chairman of the Board

Puri is an accomplished leader and financial sector veteran with over four decades of experience